BCRX earnings call for the period ending September 30, 2019.
News & Analysis: BioCryst Pharmaceuticals
Investors are thrilled with a new addition to BioCryst's board of directors.
BCRX earnings call for the period ending June 30, 2019.
A hedge fund disclosed a sizable stake in the company.
Tough conditions for these companies left them out of the day's rally.
This is a case study of when a successful phase 3 trial isn't successful enough.
BCRX earnings call for the period ending March 31, 2019.
BCRX earnings call for the period ending December 31, 2018.
Believe it or not, share prices rose after the company announced a share offering.
Investors are cheering the orphan drug specialist's decision to raise a nice chunk of capital via a public offering.